Possible application of H2S-producing compounds in therapy of coronavirus (COVID-19) infection and pneumonia

M. Evgen’ev, A. Frenkel,

2021

https://doi.org/10.1007/s12192-020-01120-1

Цитирование

Об авторах

M. Evgen’ev
Laboratory of Molecular Mechanisms of Biological Adaptations, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russian Federation
A. Frenkel
Clexio Biosciences Ltd., Petah-Tikva, Israel

Название журнала

Том

Выпуск

Страницы

Ключевые слова

anti-SARS-CoV-2 agent; hydrogen sulfide; sodium thiosulfate; antiinflammatory agent; hydrogen sulfide; sodium thiosulfate; thiosulfate; Coronavirinae; coronavirus disease 2019; drug use; human; inhalational drug administration; nonhuman; Note; pneumonia; priority journal; animal; bacterial pneumonia; Coronavirus infection; intravenous drug administration; mouse; pandemic; rat; ventilator induced lung injury; virus pneumonia; Administration, Inhalation; Animals; Anti-Inflammatory Agents; Coronavirus Infections; Humans; Hydrogen Sulfide; Injections, Intravenous; Mice; Pandemics; Pneumonia, Bacterial; Pneumonia, Viral; Rats; Thiosulfates; Ventilator-Induced Lung Injury

Издатель

Тип документа

Источник